CLARE DOSS: Open Payments
NPI 1437804085 · MARTINSVILLE, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$426 in 13 payments from 9 companies in 2025. Trend: 2023 $1,778 · 2024 $369 · 2025 $426
Food & beverage: $426
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 3 | $148 |
| AstraZeneca Pharmaceuticals LP | 1 | $113 |
| ABBVIE INC. | 2 | $43 |
| PFIZER INC. | 2 | $34 |
| Axsome Therapeutics, Inc. | 1 | $19 |
| Lilly USA, LLC | 1 | $18 |
| Otsuka America Pharmaceutical, Inc. | 1 | $18 |
| Dexcom, Inc. | 1 | $17 |
| Amgen Inc. | 1 | $16 |
Products named: Ozempic, BREZTRI, PREVNAR 20, VRAYLAR, QULIPTA, Auvelity, MOUNJARO, REXULTI.
Industry payments across VA — which companies pay providers there.
